Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-03-06
DOI
10.1007/s40262-018-0639-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
- (2018) Geert D’Haens et al. GASTROENTEROLOGY
- Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease
- (2018) Maria Rosario et al. Journal of Crohns & Colitis
- American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
- (2017) Niels Vande Casteele et al. GASTROENTEROLOGY
- Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol–Thiopurine Combination Therapy
- (2017) Margien L. Seinen et al. INFLAMMATORY BOWEL DISEASES
- Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease
- (2017) Xavier Roblin et al. INFLAMMATORY BOWEL DISEASES
- Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?
- (2017) Erwin Dreesen et al. Journal of Crohns & Colitis
- 6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients
- (2017) Berrie Meijer et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Azathioprine Therapy in a Pediatric TPMT-Deficient Patient—Still an Option
- (2017) S. A. W. van Moorsel et al. THERAPEUTIC DRUG MONITORING
- Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis
- (2016) G. D'Haens ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease
- (2016) D. R. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort
- (2016) Steven F G Jeuring et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Ustekinumab: a novel therapeutic option in Crohn’s disease
- (2016) E. G. Simon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
- (2016) Franck Carbonnel et al. GASTROENTEROLOGY
- Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
- (2016) I Oancea et al. GUT
- The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease
- (2016) Dirk P. van Asseldonk et al. INFLAMMATORY BOWEL DISEASES
- An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
- (2016) Tim Wyant et al. Journal of Crohns & Colitis
- Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease
- (2016) Dennis R. Wong et al. Journal of Crohns & Colitis
- Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis
- (2016) Iris Detrez et al. Journal of Crohns & Colitis
- Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies
- (2016) Omoniyi J. Adedokun et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Mechanism of action of methotrexate in rheumatoid arthritis and the search for biomarkers
- (2016) Philip M. Brown et al. Nature Reviews Rheumatology
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
- (2016) Giorgia Bodini et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease
- (2016) Berrie Meijer et al. THERAPEUTIC DRUG MONITORING
- Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease
- (2016) Margien L. Seinen et al. THERAPEUTIC DRUG MONITORING
- Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
- (2016) Parakkal Deepak et al. Drug Design Development and Therapy
- Golimumab pharmacokinetics in ulcerative colitis: a literature review
- (2016) Ines Harzallah et al. Therapeutic Advances in Gastroenterology
- Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
- (2015) M. Rosario et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients
- (2015) Sakiko Hiraoka et al. BMC GASTROENTEROLOGY
- Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease
- (2015) Walter Reinisch et al. Clinical Gastroenterology and Hepatology
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
- (2015) Andres J. Yarur et al. Clinical Gastroenterology and Hepatology
- The Pharmacokinetics of Biologics: A Primer
- (2015) Diane R. Mould DIGESTIVE DISEASES
- Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis
- (2015) David T. Rubin et al. DIGESTIVE DISEASES AND SCIENCES
- Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
- (2015) Sheridan M. Hoy DRUGS
- Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
- (2015) E. G. Quetglas et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting
- (2015) Andrea Warman et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
- (2015) Marieke J.H. Coenen et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
- (2015) Filip Baert et al. GUT
- Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
- (2015) Janet R. Wade et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement
- (2015) Bindia Jharap et al. PLoS One
- Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
- (2014) F. Baert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
- (2014) Y. Mazor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Xavier Roblin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
- (2014) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
- (2014) Freddy Cornillie et al. GUT
- Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Crohn's disease
- (2014) R. Kalla et al. BMJ-British Medical Journal
- Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
- (2013) R. Khanna et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mechanism of allopurinol induced TPMT inhibition
- (2013) P.A. Blaker et al. BIOCHEMICAL PHARMACOLOGY
- Implementation of TPMT testing
- (2013) Lynne Lennard BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease
- (2013) Margien L. Seinen et al. Clinical Gastroenterology and Hepatology
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease
- (2013) Yi-Lin Chiu et al. INFLAMMATORY BOWEL DISEASES
- Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination
- (2013) O. M. Al-Quteimat et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study
- (2013) M.L. Seinen et al. Journal of Crohns & Colitis
- Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype
- (2013) Catherine Milch et al. JOURNAL OF NEUROIMMUNOLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
- (2012) Frank Hoentjen et al. INFLAMMATORY BOWEL DISEASES
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol
- (2012) Malin Lindqvist Appell et al. Journal of Crohns & Colitis
- Ulcerative colitis
- (2012) Ingrid Ordás et al. LANCET
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis
- (2011) M. S. Harris et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
- (2011) T. Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine
- (2011) B Jharap et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment
- (2011) Dirk P. van Asseldonk et al. Journal of Crohns & Colitis
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
- (2010) Dirk Van Asseldonk et al. CURRENT DRUG METABOLISM
- Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting
- (2010) Dirk P. van Asseldonk et al. DIGESTIVE AND LIVER DISEASE
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
- (2010) Anne Christine W. Vos et al. GASTROENTEROLOGY
- Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease
- (2010) Irene Sonu et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
- (2010) B. Jharap et al. INFLAMMATORY BOWEL DISEASES
- Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines
- (2010) Andrea Walch et al. Journal of Crohns & Colitis
- Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis
- (2010) Shigeki Bamba et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio
- (2010) Sharon J Gardiner et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene
- (2010) Malin Lindqvist Appell et al. Pharmacogenetics and Genomics
- Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme
- (2009) Qiping Feng et al. BIOCHEMICAL PHARMACOLOGY
- TPMT*26 (208F→L), a novel mutation detected in a Chinese
- (2009) Shirley Kow Yin Kham et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Advances in individual prediction of methotrexate toxicity: a review
- (2009) Kjeld Schmiegelow BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease
- (2009) L. Derijks et al. CURRENT PHARMACEUTICAL DESIGN
- TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis
- (2009) Trine Olsen et al. CYTOKINE
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Biological Therapies for Inflammatory Bowel Diseases
- (2009) Paul Rutgeerts et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring
- (2009) W.G.N. Mares et al. Journal of Crohns & Colitis
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Characterisation of novel defective thiopurine S-methyltransferase allelic variants
- (2008) A. Garat et al. BIOCHEMICAL PHARMACOLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical pharmacology and pharmacogenetics of thiopurines
- (2008) Srikumar Sahasranaman et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients
- (2008) L J J Derijks et al. GUT
- Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 – *24)
- (2008) Shuta Ujiie et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More